Tapewire

OTC · USD

CFOR

CapForce Inc.

Export transactions ↓
Tapewire entity
9776
SEC CIK
0001293818
Parsed reports
144

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 23, 2026 Filed Jul 6, 2026 21:46 UTC
Yee Gillian Tan RouCorporate Secretary
GrantCommon Stock 2,778 $0.00 $0.00
Disclosure

SEC source: 0001829126-26-007303 · ownership.xml · nonDerivative · entry 1

Yee Gillian Tan Rou · CIK 0002049182 · Corporate Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,403

F1 · shares: Represents an award of restricted stock units, 100% vesting on the earlier of (i) 12/3/2026 and (ii) a change in control of the Issuer.

Read SEC document
February 23, 2026 Filed Jul 6, 2026 21:46 UTC GrantCommon Stock 5,555 $0.00 $0.00
Disclosure

SEC source: 0001829126-26-007301 · ownership.xml · nonDerivative · entry 1

Wong Poh Yin Constance · CIK 0002035733 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,126

F1 · shares: Represents an award of restricted stock units, 100% vesting on the earlier of (i) 12/3/2026 and (ii) a change in control of the Issuer.

Read SEC document
February 23, 2026 Filed Jul 6, 2026 21:47 UTC GrantCommon Stock 5,555 $0.00 $0.00
Disclosure

SEC source: 0001829126-26-007304 · ownership.xml · nonDerivative · entry 1

Lim Zhao Qi Ken · CIK 0002035787 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,126

F1 · shares: Represents an award of restricted stock units, 100% vesting on the earlier of (i) 12/3/2026 and (ii) a change in control of the Issuer.

Read SEC document
February 23, 2026 Filed Jul 6, 2026 21:46 UTC GrantCommon Stock 5,555 $0.00 $0.00
Disclosure

SEC source: 0001829126-26-007302 · ownership.xml · nonDerivative · entry 1

Low Yu Jie Ethan · CIK 0002035809 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,126

F1 · shares: Represents an award of restricted stock units, 100% vesting on the earlier of (i) 12/3/2026 and (ii) a change in control of the Issuer.

Read SEC document
February 23, 2026 Filed Jul 6, 2026 21:48 UTC GrantCommon Stock 5,555 $0.00 $0.00
Disclosure

SEC source: 0001829126-26-007306 · ownership.xml · nonDerivative · entry 1

Chua Kok Hoe Victor · CIK 0002035897 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,126

F1 · shares: Represents an award of restricted stock units, 100% vesting on the earlier of (i) 12/3/2026 and (ii) a change in control of the Issuer.

Read SEC document
February 23, 2026 Filed Jul 6, 2026 21:47 UTC GrantCommon Stock 5,555 $0.00 $0.00
Disclosure

SEC source: 0001829126-26-007305 · ownership.xml · nonDerivative · entry 1

Azudin Mohd Azham · CIK 0002036005 · COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,805

F1 · shares: Represents an award of restricted stock units, 100% vesting on the earlier of (i) 12/3/2026 and (ii) a change in control of the Issuer.

Read SEC document
July 30, 2025 Filed Jul 30, 2025 14:04 UTC PurchaseCommon Stock 1,000 $4.79 $4,790.00
Disclosure

SEC source: 0001829126-25-005591 · ownership.xml · nonDerivative · entry 1

AEI Capital Ltd · CIK 0002034863 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,646,603

Read SEC document
April 08, 2025 Filed Apr 30, 2025 16:32 UTC
Syed Mohd Syed Johan BinChief Technology Officer (CTO)
GrantCommon Stock 9,709 $0.00 $0.00
Disclosure

SEC source: 0001829126-25-003196 · ownership.xml · nonDerivative · entry 1

Syed Mohd Syed Johan Bin · CIK 0002066245 · Chief Technology Officer (CTO)

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,709

F1 · balance_after: Represents an award of restricted stock units vesting on the earlier of the (i) first anniversary of the CTO's appointment in the Company and (ii) a change in control; provided that the award is expressly conditioned upon the receipt of stockholder approval of a new equity incentive plan.

Read SEC document
December 04, 2024 Filed Dec 19, 2024 21:32 UTC
Yee Gillian Tan RouCorporate Secretary
GrantCommon Stock 15,625 $0.00 $0.00
Disclosure

SEC source: 0001829126-24-008420 · ownership.xml · nonDerivative · entry 1

Yee Gillian Tan Rou · CIK 0002049182 · Corporate Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,625

F1 · balance_after: Represents an award of restricted stock units vesting on the earlier of the (i) first anniversary of the Corporate Secretary's appointment in the Company and (ii) a change in control; provided that the award is expressly conditioned upon the receipt of stockholder approval of a new equity incentive plan.

Read SEC document
December 04, 2024 Filed Dec 19, 2024 21:33 UTC GrantCommon Stock 31,250 $0.00 $0.00
Disclosure

SEC source: 0001829126-24-008423 · ownership.xml · nonDerivative · entry 1

Azudin Mohd Azham · CIK 0002036005 · COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,250

F1 · balance_after: Represents an award of restricted stock units vesting on the earlier of the (i) first anniversary of the COO's appointment in the Company and (ii) a change in control; provided that the award is expressly conditioned upon the receipt of stockholder approval of a new equity incentive plan.

Read SEC document
November 12, 2024 Filed Dec 19, 2024 21:34 UTC GrantCommon Stock 28,571 $0.00 $0.00
Disclosure

SEC source: 0001829126-24-008425 · ownership.xml · nonDerivative · entry 1

Wong Poh Yin Constance · CIK 0002035733 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,571

F1 · balance_after: Represents an award of restricted stock units vesting on the earlier of the (i) first anniversary of the Director's appointment to the Board of Directors of the Company and (ii) a change in control; provided that the award is expressly conditioned upon the receipt of stockholder approval of a new equity incentive plan.

Read SEC document
November 12, 2024 Filed Dec 19, 2024 21:33 UTC GrantCommon Stock 28,571 $0.00 $0.00
Disclosure

SEC source: 0001829126-24-008421 · ownership.xml · nonDerivative · entry 1

Lim Zhao Qi Ken · CIK 0002035787 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,571

F1 · balance_after: Represents an award of restricted stock units vesting on the earlier of the (i) first anniversary of the Director's appointment to the Board of Directors of the Company and (ii) a change in control; provided that the award is expressly conditioned upon the receipt of stockholder approval of a new equity incentive plan.

Read SEC document
November 12, 2024 Filed Dec 19, 2024 21:33 UTC GrantCommon Stock 28,571 $0.00 $0.00
Disclosure

SEC source: 0001829126-24-008422 · ownership.xml · nonDerivative · entry 1

Low Yu Jie Ethan · CIK 0002035809 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,571

F1 · balance_after: Represents an award of restricted stock units vesting on the earlier of the (i) first anniversary of the Director's appointment to the Board of Directors of the Company and (ii) a change in control; provided that the award is expressly conditioned upon the receipt of stockholder approval of a new equity incentive plan.

Read SEC document
November 12, 2024 Filed Dec 19, 2024 16:32 UTC GrantCommon Stock 28,571 $0.00 $0.00
Disclosure

SEC source: 0001829126-24-008419 · ownership.xml · nonDerivative · entry 1

Bonte Christian-Laurent · CIK 0002035898 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,571

F1 · balance_after: Represents an award of restricted stock units vesting on the earlier of the (i) first anniversary of the Director's appointment to the Board of Directors of the Company and (ii) a change in control; provided that the award is expressly conditioned upon the receipt of stockholder approval of a new equity incentive plan.

Read SEC document
November 12, 2024 Filed Dec 19, 2024 21:33 UTC GrantCommon Stock 28,571 $0.00 $0.00
Disclosure

SEC source: 0001829126-24-008424 · ownership.xml · nonDerivative · entry 1

Chua Kok Hoe Victor · CIK 0002035897 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,571

F1 · balance_after: Represents an award of restricted stock units vesting on the earlier of the (i) first anniversary of the Director's appointment to the Board of Directors of the Company and (ii) a change in control; provided that the award is expressly conditioned upon the receipt of stockholder approval of a new equity incentive plan.

Read SEC document
August 29, 2024 Filed Oct 8, 2024 18:51 UTC PurchaseCommon Stock 514,138 $999,998.00 $514,136,971,724.00
Disclosure

SEC source: 0002034863-24-000002 · primary_doc.xml · nonDerivative · entry 6

AEI Capital Ltd · CIK 0002034863 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,645,603

Read SEC document
August 27, 2024 Filed Oct 8, 2024 18:51 UTC PurchaseCommon Stock 564,971 $999,999.00 $564,970,435,029.00
Disclosure

SEC source: 0002034863-24-000002 · primary_doc.xml · nonDerivative · entry 5

AEI Capital Ltd · CIK 0002034863 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,131,465

Read SEC document
August 23, 2024 Filed Oct 8, 2024 18:51 UTC SaleSeries E Convertible Preferred Stock · Derivative 263,961 $1,800,000.00 Strike: $2.84 $475,129,800,000.00
Disclosure

SEC source: 0002034863-24-000002 · primary_doc.xml · derivative · entry 7

AEI Capital Ltd · CIK 0002034863 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 633,506 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of Series E Preferred Stock is convertible into 2.4 shares of the Issuer's Common Stock.

F2 · derivative.expiration_date: The Series E Preferred Stock is perpetual and therefore has no expiration date.

Read SEC document
August 16, 2024 Filed Oct 8, 2024 18:51 UTC PurchaseCommon Stock 3,600,000 $2,724,490.00 $9,808,164,000,000.00
Disclosure

SEC source: 0002034863-24-000002 · primary_doc.xml · nonDerivative · entry 4

AEI Capital Ltd · CIK 0002034863 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,566,494

Read SEC document
August 13, 2024 Filed Oct 8, 2024 18:51 UTC PurchaseCommon Stock 566,494 $428,724.00 $242,869,573,656.00
Disclosure

SEC source: 0002034863-24-000002 · primary_doc.xml · nonDerivative · entry 3

AEI Capital Ltd · CIK 0002034863 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,966,494

Read SEC document
August 08, 2024 Filed Oct 8, 2024 18:51 UTC SaleCommon Stock 600,000 $454,082.00 $272,449,200,000.00
Disclosure

SEC source: 0002034863-24-000002 · primary_doc.xml · nonDerivative · entry 2

AEI Capital Ltd · CIK 0002034863 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,400,000

Read SEC document
August 08, 2024 Filed Dec 10, 2024 12:32 UTC PurchaseCommon Stock 600,000 $454,082.00 $272,449,200,000.00
Disclosure

SEC source: 0002034863-24-000004 · primary_doc.xml · nonDerivative · entry 2

AEI Capital Ltd · CIK 0002034863 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,400,000

F1 · kind: Amended from "S" to "P"

Read SEC document
August 05, 2024 Filed Oct 8, 2024 18:51 UTC SaleCommon Stock 1,800,000 $913,265.00 $1,643,877,000,000.00
Disclosure

SEC source: 0002034863-24-000002 · primary_doc.xml · nonDerivative · entry 1

AEI Capital Ltd · CIK 0002034863 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,800,000

Read SEC document
August 05, 2024 Filed Dec 10, 2024 12:32 UTC PurchaseCommon Stock 1,800,000 $913,265.00 $1,643,877,000,000.00
Disclosure

SEC source: 0002034863-24-000004 · primary_doc.xml · nonDerivative · entry 1

AEI Capital Ltd · CIK 0002034863 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,800,000

F1 · kind: Amended from "S" to "P"

Read SEC document
July 30, 2024 Filed Aug 1, 2024 21:25 UTC
Lazar David E.Director · Chief Executive Officer · 10% owner
SaleSeries E Convertible Preferred Stock · Derivative 550,000 Not disclosed Not disclosed
Disclosure

SEC source: 0000921895-24-001668 · form412227017_08012024.xml · derivative · entry 1

Lazar David E. · CIK 0001932843 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,320,000 shares

Expires not disclosed

F1 · security: On July 30, 2024, David E. Lazar (the "Reporting Person") entered into a securies purchase agreement with AEI Capital Group, a third party, pursuant to which the Reporting Person sold (i) 550,000 shares of Series E Convertible Preferred Stock (the "Series E Preferred Stock") of OpGen, Inc. (the "Company") and (ii) the rights to acquire an additional 2,450,000 shares of Series E Preferred Stock for $2,450,000 pursuant to an agreement between the Reporting Person and the Company.

F2 · derivative.exercise_price: The shares of Series E Preferred Stock are convertible at the option of the Reporting Person for no additional consideration.

F1 · price: On July 30, 2024, David E. Lazar (the "Reporting Person") entered into a securies purchase agreement with AEI Capital Group, a third party, pursuant to which the Reporting Person sold (i) 550,000 shares of Series E Convertible Preferred Stock (the "Series E Preferred Stock") of OpGen, Inc. (the "Company") and (ii) the rights to acquire an additional 2,450,000 shares of Series E Preferred Stock for $2,450,000 pursuant to an agreement between the Reporting Person and the Company.

F3 · derivative.expiration_date: The Series E Preferred Stock is perpetual and therefore has no expiration date.

Read SEC document
April 23, 2024 Filed Apr 25, 2024 20:59 UTC
Lazar David E.Director · Chief Executive Officer · 10% owner
PurchaseSeries E Convertible Preferred Stock · Derivative 150,000 $1.00 $150,000.00
Disclosure

SEC source: 0000921895-24-000949 · form412227017_04252024.xml · derivative · entry 1

Lazar David E. · CIK 0001932843 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 550,000

Underlying: Common Stock · 3,600,000 shares

Expires not disclosed

F1 · security: On March 25, 2024, David E. Lazar (the "Reporting Person") and OpGen, Inc. (the "Company"), entered into a securies purchase agreement pursuant to which the Reporting Person will acquire an aggregate of 3,000,000 shares of the Company's Series E Convertible Preferred Stock (the "Series E Preferred Stock") at a price of $1.00 per share. Each share of Series E Preferred Stock is convertible into 24 shares of the Company's Common Stock at any time, subject to certain ownership limitations. The initial closing took place on March 25, 2024, whereby the Reporting Person acquired 200,000 shares of Series E Preferred Stock for a total purchase price of $200,000. On April 23, 2024, the Reporting Person acquired an additional 150,000 shares of Series E Preferred Stock for a total purchase price of $150,000. The Reporting Person will acquire additional shares of Series E Preferred Stock at subsequent closings, subject to certain conditions being satisfied.

F2 · derivative.exercise_price: The shares of Series E Preferred Stock are convertible at the option of the Reporting Person for no additional consideration.

F3 · derivative.expiration_date: The Series E Preferred Stock is perpetual and therefore has no expiration date.

F4 · balance_after: The Reporting Person's Form 4 filed on April 13, 2024 inadvertently included as the number of derivative securities beneficially owned the number of shares of the Company's Common Stock that would be owned following the conversion of the Series E Preferred Stock. The number of derivative securities beneficially owned is correctly reported in this Form 4.

Read SEC document
April 23, 2024 Filed Aug 1, 2024 16:26 UTC Amendment
Lazar David E.Director · Chief Executive Officer · 10% owner
GrantSeries E Convertible Preferred Stock · Derivative 150,000 $1.00 $150,000.00
Disclosure

SEC source: 0000921895-24-001661 · form4a1122270170425_07262024.xml · derivative · entry 1

Lazar David E. · CIK 0001932843 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 550,000

Underlying: Common Stock · 360,000 shares

Expires not disclosed

F1 · security: On March 25, 2024, David E. Lazar (the "Reporting Person") and OpGen, Inc. (the "Company"), entered into a securies purchase agreement pursuant to which the Reporting Person will acquire an aggregate of 3,000,000 shares of the Company's Series E Convertible Preferred Stock (the "Series E Preferred Stock") at a price of $1.00 per share. Each share of Series E Preferred Stock is convertible into 24 shares of the Company's Common Stock at any time, subject to certain ownership limitations. The initial closing took place on March 25, 2024, whereby the Reporting Person acquired 200,000 shares of Series E Preferred Stock for a total purchase price of $200,000. On April 23, 2024, the Reporting Person acquired an additional 150,000 shares of Series E Preferred Stock for a total purchase price of $150,000. The Reporting Person will acquire additional shares of Series E Preferred Stock at subsequent closings, subject to certain conditions being satisfied.

F2 · derivative.exercise_price: The shares of Series E Preferred Stock are convertible at the option of the Reporting Person for no additional consideration.

F3 · kind: This Form 4/A is being filed solely to change the transaction code previously provided to identify the transaction reported as exempt from Section 16(b) pursuant to Rule 16b-3

F4 · derivative.expiration_date: The Series E Preferred Stock is perpetual and therefore has no expiration date.

F5 · derivative.underlying_shares: The reported number of shares of Common Stock underlying the shares of Series E Preferred Stock has been adjusted to reflect a reverse stock split of the Company's Common Stock effective as of May 20, 2024.

Read SEC document
April 11, 2024 Filed Apr 12, 2024 17:04 UTC GrantCommon Stock 100,000 Not disclosed Not disclosed
Disclosure

SEC source: 0000921895-24-000830 · form412227017mcm_04122024.xml · nonDerivative · entry 1

McMurdo Matthew Charles · CIK 0001943108 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

F1 · price: Shares of restricted stock issued pursuant to the 2015 Equity Incentive Plan of OpGen, Inc.

Read SEC document
April 11, 2024 Filed Apr 12, 2024 21:05 UTC
NATAN DAVIDDirector
GrantCommon Stock 100,000 Not disclosed Not disclosed
Disclosure

SEC source: 0000921895-24-000831 · form412227017nat_04122024.xml · nonDerivative · entry 1

NATAN DAVID · CIK 0001253108 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

F1 · price: Shares of restricted stock issued pursuant to the 2015 Equity Incentive Plan of OpGen, Inc.

Read SEC document
April 11, 2024 Filed Apr 12, 2024 21:03 UTC
Lazar David E.Director · Chief Executive Officer · 10% owner
GrantCommon Stock 100,000 Not disclosed Not disclosed
Disclosure

SEC source: 0000921895-24-000829 · form412227017laz_04122024.xml · nonDerivative · entry 1

Lazar David E. · CIK 0001932843 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

F1 · price: Shares of restricted stock issued pursuant to the 2015 Equity Incentive Plan of OpGen, Inc.

Read SEC document
April 11, 2024 Filed Apr 15, 2024 13:07 UTC GrantCommon Stock 100,000 Not disclosed Not disclosed
Disclosure

SEC source: 0000921895-24-000834 · form412227017ben_04122024.xml · nonDerivative · entry 1

Ben-Tzvi Avraham · CIK 0001944721 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

F1 · price: Shares of restricted stock issued pursuant to the 2015 Equity Incentive Plan of OpGen, Inc.

Read SEC document
April 05, 2024 Filed Apr 8, 2024 20:06 UTC
Lazar David E.Director · Chief Executive Officer · 10% owner
PurchaseSeries E Convertible Preferred Stock · Derivative 200,000 $1.00 $200,000.00
Disclosure

SEC source: 0000921895-24-000813 · form412227017_04082024.xml · derivative · entry 1

Lazar David E. · CIK 0001932843 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,600,000

Underlying: Common Stock · 4,800,000 shares

Expires not disclosed

F1 · security: On March 25, 2024, David E. Lazar (the "Reporting Person") and OpGen, Inc. (the "Company"), entered into a securies purchase agreement pursuant to which the Reporting Person will acquire an aggregate of 3,000,000 shares of the Company's Series E Convertible Preferred Stock (the "Series E Preferred Stock") at a price of $1.00 per share. Each share of Series E Preferred Stock is convertible into 24 shares of the Company's Common Stock at any time, subject to certain ownership limitations. The initial closing took place on March 25, 2024, whereby the Reporting Person acquired 200,000 shares of Series E Preferred Stock for a total purchase price of $200,000. An additional closing occurred on April 5, 2024, whereby the Reporting Person acquired 200,000 shares of Series E Preferred Stock for a total purchase price of $200,000. The Reporting Person will acquire additional shares of Series E Preferred Stock at subsequent closings, subject to certain conditions being satisfied.

F2 · derivative.exercise_price: The shares of Series E Preferred Stock are convertible at the option of the Reporting Person for no additional consideration.

F3 · derivative.expiration_date: The Series E Preferred Stock is perpetual and therefore has no expiration date.

Read SEC document
April 05, 2024 Filed Jul 31, 2024 23:05 UTC Amendment
Lazar David E.Director · Chief Executive Officer · 10% owner
GrantSeries E Convertible Preferred Stock · Derivative 200,000 $1.00 $200,000.00
Disclosure

SEC source: 0000921895-24-001652 · form4a1122270170408_07262024.xml · derivative · entry 1

Lazar David E. · CIK 0001932843 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 480,000 shares

Expires not disclosed

F1 · security: On March 25, 2024, David E. Lazar (the "Reporting Person") and OpGen, Inc. (the "Company"), entered into a securies purchase agreement pursuant to which the Reporting Person will acquire an aggregate of 3,000,000 shares of the Company's Series E Convertible Preferred Stock (the "Series E Preferred Stock") at a price of $1.00 per share. Each share of Series E Preferred Stock is convertible into 24 shares of the Company's Common Stock at any time, subject to certain ownership limitations. The initial closing took place on March 25, 2024, whereby the Reporting Person acquired 200,000 shares of Series E Preferred Stock for a total purchase price of $200,000. An additional closing occurred on April 5, 2024, whereby the Reporting Person acquired 200,000 shares of Series E Preferred Stock for a total purchase price of $200,000. The Reporting Person will acquire additional shares of Series E Preferred Stock at subsequent closings, subject to certain conditions being satisfied.

F2 · derivative.exercise_price: The shares of Series E Preferred Stock are convertible at the option of the Reporting Person for no additional consideration.

F3 · kind: This Form 4/A is being filed solely to change the transaction code previously provided to identify the transaction reported as exempt from Section 16(b) pursuant to Rule 16b-3.

F4 · derivative.expiration_date: The Series E Preferred Stock is perpetual and therefore has no expiration date.

F5 · derivative.underlying_shares: The reported number of shares of Common Stock underlying the shares of Series E Preferred Stock has been adjusted to reflect a reverse stock split of the Company's Common Stock effective as of May 20, 2024.

Read SEC document
June 07, 2023 Filed Jun 9, 2023 16:32 UTC GrantCommon Stock 1,500 $0.00 $0.00
Disclosure

SEC source: 0001079973-23-000849 · ownership.xml · nonDerivative · entry 1

Crovetto Mario · CIK 0001808675 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,000

F1 · security: Represents an award of restricted stock units vesting on the first anniversary of the date of grant, or if earlier, the date of the 2024 annual meeting of stockholders, subject to acceleration and vesting if the director leaves the Board of Directors in connection with a change in control of OpGen, Inc. (the "Company").

F2 · balance_after: The number of restricted stock units and shares reflects the application of the twenty-for-one reverse stock split effected by the Company on January 5, 2023.

Read SEC document
June 07, 2023 Filed Jun 9, 2023 20:35 UTC GrantCommon Stock 1,500 $0.00 $0.00
Disclosure

SEC source: 0001079973-23-000853 · ownership.xml · nonDerivative · entry 1

Schlaeppi Yvonne · CIK 0001736515 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,000

F1 · security: Represents an award of restricted stock units vesting on the first anniversary of the date of grant, or if earlier, the date of the 2024 annual meeting of stockholders, subject to acceleration and vesting if the director leaves the Board of Directors in connection with a change in control of OpGen, Inc. (the "Company").

F2 · balance_after: The number of restricted stock units and shares reflects the application of the twenty-for-one reverse stock split effected by the Company on January 5, 2023.

Read SEC document
June 07, 2023 Filed Jun 9, 2023 20:34 UTC GrantCommon Stock 1,500 $0.00 $0.00
Disclosure

SEC source: 0001079973-23-000852 · ownership.xml · nonDerivative · entry 1

Rhodes William E. · CIK 0001532276 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,000

F1 · security: Represents an award of restricted stock units vesting on the first anniversary of the date of grant, or if earlier, the date of the 2024 annual meeting of stockholders, subject to acceleration and vesting if the director leaves the Board of Directors in connection with a change in control of OpGen, Inc. (the "Company").

F2 · balance_after: The number of restricted stock units and shares reflects the application of the twenty-for-one reverse stock split effected by the Company on January 5, 2023.

Read SEC document
June 07, 2023 Filed Jun 9, 2023 20:33 UTC GrantCommon Stock 1,500 $0.00 $0.00
Disclosure

SEC source: 0001079973-23-000851 · ownership.xml · nonDerivative · entry 1

Fernandes Prabhavathi · CIK 0001540883 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,000

F1 · security: Represents an award of restricted stock units vesting on the first anniversary of the date of grant, or if earlier, the date of the 2024 annual meeting of stockholders, subject to acceleration and vesting if the director leaves the Board of Directors in connection with a change in control of OpGen, Inc. (the "Company").

F2 · balance_after: The number of restricted stock units and shares reflects the application of the twenty-for-one reverse stock split effected by the Company on January 5, 2023.

Read SEC document
June 07, 2023 Filed Jun 9, 2023 20:32 UTC
Elsey R DonDirector
GrantCommon Stock 1,500 $0.00 $0.00
Disclosure

SEC source: 0001079973-23-000850 · ownership.xml · nonDerivative · entry 1

Elsey R Don · CIK 0001380742 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,075

F1 · security: Represents an award of restricted stock units vesting on the first anniversary of the date of grant, or if earlier, the date of the 2024 annual meeting of stockholders, subject to acceleration and vesting if the director leaves the Board of Directors in connection with a change in control of OpGen, Inc. (the "Company").

F2 · balance_after: The number of restricted stock units and shares reflects the application of the twenty-for-one reverse stock split effected by the Company on January 5, 2023.

Read SEC document
March 31, 2023 Filed Mar 31, 2023 16:30 UTC
Bacher JohannesChief Operating Officer
Exercise / conversionRestricted Stock Units · Derivative 6,434 $0.00 $0.00
Disclosure

SEC source: 0001079973-23-000409 · ownership.xml · derivative · entry 2

Bacher Johannes · CIK 0001808765 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,434 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Represents vesting of restricted stock units ("RSUs") granted to Reporting Person on March 31, 2022 that convert into common stock on a one-for-one basis as adjusted for a 1-for-20 reverse stock split.

F2 · derivative.exercise_date: On March 31, 2022, the Reporting Person was granted 6,434 RSUs (as adjusted for a 1-for-20 reverse stock split). The RSUs were granted subject to forfeiture, which forfeiture restrictions lapsed on the first anniversary of the date of grant.

F2 · derivative.expiration_date: On March 31, 2022, the Reporting Person was granted 6,434 RSUs (as adjusted for a 1-for-20 reverse stock split). The RSUs were granted subject to forfeiture, which forfeiture restrictions lapsed on the first anniversary of the date of grant.

Read SEC document
March 31, 2023 Filed Mar 31, 2023 16:30 UTC
Bacher JohannesChief Operating Officer
Exercise / conversionCommon Stock 6,434 $0.00 $0.00
Disclosure

SEC source: 0001079973-23-000409 · ownership.xml · nonDerivative · entry 1

Bacher Johannes · CIK 0001808765 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,684

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 31, 2023 Filed Mar 31, 2023 16:30 UTC
Schacht OliverDirector · Chief Executive Officer
Exercise / conversionRestricted Stock Units · Derivative 12,469 $0.00 $0.00
Disclosure

SEC source: 0001079973-23-000408 · ownership.xml · derivative · entry 3

Schacht Oliver · CIK 0001808932 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,469 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Represents vesting of restricted stock units ("RSUs") granted to Reporting Person on March 31, 2022 that convert into common stock on a one-for-one basis as adjusted for a 1-for-20 reverse stock split.

F2 · derivative.exercise_date: On March 31, 2022, the Reporting Person was granted 12,469 RSUs (as adjusted for a 1-for-20 reverse stock split). The RSUs were granted subject to forfeiture, which forfeiture restrictions lapsed on the first anniversary of the date of grant.

F2 · derivative.expiration_date: On March 31, 2022, the Reporting Person was granted 12,469 RSUs (as adjusted for a 1-for-20 reverse stock split). The RSUs were granted subject to forfeiture, which forfeiture restrictions lapsed on the first anniversary of the date of grant.

Read SEC document
March 31, 2023 Filed Mar 31, 2023 16:30 UTC
Schacht OliverDirector · Chief Executive Officer
Exercise / conversionCommon Stock 12,469 $0.00 $0.00
Disclosure

SEC source: 0001079973-23-000408 · ownership.xml · nonDerivative · entry 1

Schacht Oliver · CIK 0001808932 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,719

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 03, 2023 Filed Mar 6, 2023 17:15 UTC
Schacht OliverDirector · Chief Executive Officer
Exercise / conversionRestricted Stock Units · Derivative 1,938 $0.00 $0.00
Disclosure

SEC source: 0001079973-23-000290 · ownership.xml · derivative · entry 4

Schacht Oliver · CIK 0001808932 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,938

Underlying: Common Stock · 1,938 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Represents vesting of restricted stock units ("RSUs") granted in March 2021 that convert into common stock on a one-for-one basis as adjusted for a 1-for-20 reverse stock split.

F2 · derivative.exercise_date: On March 3, 2021, the Reporting Person was granted 3,875 RSUs (as adjusted for a 1-for-20 reverse stock split). The RSUs were granted subject to forfeiture, which forfeiture restrictions will lapse as to one half of the award on the first and second anniversaries of the date of grant, subject to acceleration as set forth in the Reporting Person's employment agreement with the Registrant.

F2 · derivative.expiration_date: On March 3, 2021, the Reporting Person was granted 3,875 RSUs (as adjusted for a 1-for-20 reverse stock split). The RSUs were granted subject to forfeiture, which forfeiture restrictions will lapse as to one half of the award on the first and second anniversaries of the date of grant, subject to acceleration as set forth in the Reporting Person's employment agreement with the Registrant.

Read SEC document
March 03, 2023 Filed Mar 6, 2023 17:15 UTC
Schacht OliverDirector · Chief Executive Officer
Exercise / conversionCommon Stock 1,938 $0.00 $0.00
Disclosure

SEC source: 0001079973-23-000290 · ownership.xml · nonDerivative · entry 2

Schacht Oliver · CIK 0001808932 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,250

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 03, 2023 Filed Mar 6, 2023 17:13 UTC
Bacher JohannesChief Operating Officer
Exercise / conversionRestricted Stock Units · Derivative 1,063 $0.00 $0.00
Disclosure

SEC source: 0001079973-23-000288 · ownership.xml · derivative · entry 3

Bacher Johannes · CIK 0001808765 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,063

Underlying: Common Stock · 1,063 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Represents vesting of restricted stock units ("RSUs") granted in March 2021 that convert into common stock on a one-for-one basis as adjusted for a 1-for-20 reverse stock split.

F2 · derivative.exercise_date: On March 3, 2021, the Reporting Person was granted 2,125 RSUs (as adjusted for a 1-for-20 reverse stock split). The RSUs were granted subject to forfeiture, which forfeiture restrictions will lapse as to one half of the award on the first and second anniversaries of the date of grant, subject to acceleration as set forth in the Reporting Person's employment agreement with the Registrant.

F2 · derivative.expiration_date: On March 3, 2021, the Reporting Person was granted 2,125 RSUs (as adjusted for a 1-for-20 reverse stock split). The RSUs were granted subject to forfeiture, which forfeiture restrictions will lapse as to one half of the award on the first and second anniversaries of the date of grant, subject to acceleration as set forth in the Reporting Person's employment agreement with the Registrant.

Read SEC document
March 03, 2023 Filed Mar 6, 2023 17:13 UTC
Bacher JohannesChief Operating Officer
Exercise / conversionCommon Stock 1,063 $0.00 $0.00
Disclosure

SEC source: 0001079973-23-000288 · ownership.xml · nonDerivative · entry 2

Bacher Johannes · CIK 0001808765 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,250

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 02, 2023 Filed Mar 6, 2023 17:17 UTC
Weber AlbertChief Finanical Officer
GrantRestricted Stock Unit · Derivative 10,000 $0.00 $0.00
Disclosure

SEC source: 0001079973-23-000291 · ownership.xml · derivative · entry 1

Weber Albert · CIK 0001900938 · Chief Finanical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of OpGen common stock

F2 · derivative.exercise_date: RSUs granted on March 2, 2023 pursuant to the OpGen 2015 Equity Incentive Plan. The RSUs have a two year vesting schedule, vesting annually in equal installments on the anniversary of March 2, 2023.

F2 · derivative.expiration_date: RSUs granted on March 2, 2023 pursuant to the OpGen 2015 Equity Incentive Plan. The RSUs have a two year vesting schedule, vesting annually in equal installments on the anniversary of March 2, 2023.

Read SEC document
March 02, 2023 Filed Mar 6, 2023 17:15 UTC
Schacht OliverDirector · Chief Executive Officer
GrantRestricted Stock Units · Derivative 10,000 $0.00 $0.00
Disclosure

SEC source: 0001079973-23-000290 · ownership.xml · derivative · entry 6

Schacht Oliver · CIK 0001808932 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires not disclosed

F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of OpGen common stock.

F6 · derivative.exercise_date: RSUs granted on March 2, 2023 pursuant to the OpGen 2015 Equity Incentive Plan. The RSUs have a two year vesting schedule, vesting annually in equal installments on the anniversary of March 2, 2023.

F6 · derivative.expiration_date: RSUs granted on March 2, 2023 pursuant to the OpGen 2015 Equity Incentive Plan. The RSUs have a two year vesting schedule, vesting annually in equal installments on the anniversary of March 2, 2023.

Read SEC document
March 02, 2023 Filed Mar 6, 2023 17:15 UTC
Schacht OliverDirector · Chief Executive Officer
Exercise / conversionRestricted Stock Units · Derivative 1,875 $0.00 $0.00
Disclosure

SEC source: 0001079973-23-000290 · ownership.xml · derivative · entry 5

Schacht Oliver · CIK 0001808932 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,875

Underlying: Common Stock · 1,875 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Represents vesting of restricted stock units ("RSUs") granted in March 2022 that convert into common stock on a one-for-one basis as adjusted for a 1-for-20 reverse stock split.

F4 · derivative.exercise_date: On March 2, 2022, the Reporting Person was granted 3,750 RSUs (as adjusted for a 1-for-20 reverse stock split). The RSUs were granted subject to forfeiture, which forfeiture restrictions will lapse as to one half of the award on the first and second anniversaries of the date of grant, subject to acceleration as set forth in the Reporting Person's employment agreement with the Registrant.

F4 · derivative.expiration_date: On March 2, 2022, the Reporting Person was granted 3,750 RSUs (as adjusted for a 1-for-20 reverse stock split). The RSUs were granted subject to forfeiture, which forfeiture restrictions will lapse as to one half of the award on the first and second anniversaries of the date of grant, subject to acceleration as set forth in the Reporting Person's employment agreement with the Registrant.

Read SEC document
March 02, 2023 Filed Mar 6, 2023 17:15 UTC
Schacht OliverDirector · Chief Executive Officer
Exercise / conversionCommon Stock 1,875 $0.00 $0.00
Disclosure

SEC source: 0001079973-23-000290 · ownership.xml · nonDerivative · entry 1

Schacht Oliver · CIK 0001808932 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,312

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.